| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.783 | 2.529 | 2.907 | 3.080 | 3.508 | 2.804 | 3.043 | 2.369 | 1.791 | 832 |
| Total Income - EUR | 2.783 | 2.529 | 2.907 | 3.080 | 3.508 | 2.804 | 3.043 | 2.369 | 1.791 | 832 |
| Total Expenses - EUR | 2.526 | 2.586 | 2.566 | 2.625 | 3.241 | 2.433 | 2.707 | 1.547 | 1.100 | 625 |
| Gross Profit/Loss - EUR | 257 | -57 | 341 | 454 | 266 | 372 | 336 | 822 | 692 | 207 |
| Net Profit/Loss - EUR | 174 | -134 | 254 | 362 | 161 | 287 | 245 | 755 | 474 | 207 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biomed Asistence Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.066 | 5.029 | 3.985 | 3.128 | 2.144 | 1.198 | 65 | 65 | 0 | 0 |
| Current Assets | 3.283 | 674 | 1.961 | 2.648 | 3.734 | 4.127 | 3.850 | 2.688 | 2.224 | 3.499 |
| Inventories | 83 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.837 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 815 | 1.121 |
| Cash | 3.200 | 674 | 1.961 | 2.648 | 3.734 | 4.127 | 3.850 | 2.688 | 1.408 | 542 |
| Shareholders Funds | 9.096 | 949 | 1.318 | 1.171 | 1.309 | 1.065 | 1.286 | 2.045 | 1.760 | 2.707 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 254 | 4.753 | 4.628 | 4.605 | 4.569 | 4.260 | 2.629 | 708 | 463 | 793 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Biomed Asistence Srl